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ABSTRACT
We describe the utility and impact of a distributed 
leadership model to implement a National Health Service 
(NHS) England Academic Health Sciences national 
quality improvement programme, in the West Midlands. 
This model was adopted to address the inherent 
difficulties of implementing change in practice in a large 
geographical region with a diverse population of health 
service personnel. We report on the inclusion of a senior 
trainee as part of the implementation team, supported 
by a multidisciplinary clinical consultant team, with 
equal agency in decision making, acting as mentors and 
activators in the background.
INTRODUCTION
The problem
In December 2018, the West Midlands 
Academic Health Science Network 
(WMAHSN) was tasked with the spread 
of a quality improvement programme, 
Preventing Cerebral Palsy in Preterm 
babies (PReCePT) for the region, as part 
of the National Academic Health Science 
Network thrust to deliver this innovation 
to the country at scale and pace.1 PReCePT 
focused on increasing uptake of magne-
sium sulphate (MgSO4) administration 
to mothers in established preterm labour 
<30 weeks gestation, to reduce the risks of 
cerebral palsy in their preterm babies.2 The 
WMAHSN was the last network to engage 
in this national implementation work. The 
region had the worst 2017 baseline uptake 
of MgSO4 at this stage (58.6%
3); targets of 
85% were set by the national programme.2
The leadership model employed by the 
national PReCePT programme included 
a single clinical lead per region providing 
oversight, support and guidance to nomi-
nated trust- based obstetric and neonatal 
PReCePT team leads. These team leads then 
cascaded information within their respec-
tive organisations with progress fed back to 
the regional and national PReCePT team.
For the West Midlands, this single clinical 
model posed significant challenges: first, 
the region stretches over 90 miles South to 
North and East to West covering 5000 square 
miles and encompassed 14 obstetric and 14 
neonatal units, in 13 hospital trusts. Time 
constraints dictated by geographical size 
and number of providers made face to face 
discussions and support, if led by a single 
individual, less likely to succeed. Second, 
the obstetric and neonatal services varied in 
the clinical exposure (number of cases) in 
dealing with preterm pregnancies eligible 
for this intervention (24+0–29+6 weeks). 
These ranged from just 1 eligible case per 
year at maternity services linked to 4 special 
care baby neonatal units (caring for the 
bigger baby, less ill), to 80 eligible cases 
per year in those maternity services linked 
to 5 neonatal intensive care units (NICU) 
(caring for the sickest and most premature 
of babies), and 5 local neonatal units (LNU) 
(intermediate capabilities for neonatal 
care). This together with a diversely expe-
rienced workforce meant that different 
levels of support for implantation of change 
would be required.
Rationale and aim
These challenges were acknowledged and 
reflections on learning from the Health 
Foundation,4 highlighting that successful 
spread of innovation in the National Health 
Service (NHS) needs to focus on the needs 
of those adopting the innovation and their 
context and not the innovation itself. To not 
do so would risk the pace and results from 
spread of innovation to the West Midlands 
achieving the expected national targets. To 
overcome these challenges, a novel team 
structure was developed, modelled around 
distributed leadership in effecting the 
spread challenge.
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The distributed leadership model used
We focused on distributed leadership as a collection of 
leadership approaches including collaborative, coordi-
nated, shared working without a hierarchical body ‘in 
charge’.5 6 There are many variation in terms, but the most 
appropriate for our purposes is a description by Bennett 
et al7 who proposed that distributed leadership is based 
on three characteristics: (a) people making a concretive 
effort to work together to pool initiative, expertise and 
influence; (b) that leadership can include people at all 
levels in an organisation and (c) difference of expertise, 
perspectives and capabilities are harnessed to forge trust 
and reciprocal influence.
We reflected on Currie and Lockett’s6 perspectives of 
Gronn’s8 dimensions of concretive action and conjoint 
agency, for distributed leadership in NHS practice. While 
Gronn’s model represents a ‘pure’ application of distrib-
uted leadership, most NHS practice involves transforma-
tion leadership which tends towards a heroic autocratic 
approach with little concertive action or conjoint agency. 
We understood that the extent to which these dimensions 
interact is influenced by the organisational and policy 
context and this then determines different conceptions 
of distributed leadership in practice.
For the NHS, over the last decade, ‘distributed leader-
ship’ has been promoted to deliver change across health 
systems. The essence of this leadership in the NHS5 can 
be seen within the NHS Leadership Academy’s Leader-
ship Model,9 Developing People—Improving Care10 and 
the NHS Change Model.11 However, the practical reality is 
that NHS policy context is largely transactional in nature, 
promoting a heroic autocratic approach to leadership. 
This heavily influences the extent to which conjoint 
agency and concretive action can be enacted when 
distributed leadership approaches are being adopted.6 In 
the context of the PReCePT implementation project, it 
was felt that taking a single person approach to clinical 
leadership would not address the regional challenges of 
meeting the needs of those adopting the innovation and 
their context. The distributed leadership model planned, 
and subsequently adopted by this project, was heavily 
influenced by Gronn’s8 description and what Currie 
and Lockett6 refer to as ‘pure’ distributed leadership. 
Centred on the needs of the innovation adopters, it was 
intentionally designed through concretive action to enact 
the three characteristics of conjoint agency. The model 
embraced a participatory philosophy of commitment to 
empowerment through sharing of knowledge, planning, 
acting, monitoring and reflecting,12 to address the spread 
challenge.
METHOD
1. The four stages in the development of the model, its 
impact on quarterly uptake rates for the region for the 
period of implementation (April 2019–March 2020), 
additional output and our collective reflections that 
this facilitated is described. All obstetric and neonatal 
units participated in the regional implementation 
programme.
2. The WMAHSN conducted an end of project evaluation 
that included a request for stakeholders to complete a 
questionnaire. Seven questions were designed to un-
derstand how regional project leadership was experi-
enced by key trust- based individuals in a way that was 
participatory and meet their needs. The key findings 
of this evaluation are described in this paper.
RESULTS
Developing the intervention (distributed leadership model)
1. The initial call out: when approached by the WMAHSN 
to be the delivery vehicle to implement the quality im-
provement project in the region, a regional call out 
was sent by the WMAHSN for a volunteer to take on a 
funded role of the single regional clinical lead. Despite 
by this time, all trusts having local multidisciplinary 
PReCePT teams in place, this call was not answered.
2. A distributed leadership model for the West Midlands 
project was conceived and promoted: in attempting to 
understand the reasons for the call out not being an-
swered, a 1:1 discussion was held with a senior neona-
tologist in the region. The challenges outlined above 
were acknowledged, reviewed by the WMAHSN project 
lead and a team approach with a distributed leadership 
across the discipline of obstetrics and neonatology pro-
moted. WMAHSN funding for two programmed activi-
ties per month per candidate was approved.
3. A second call out for regional clinical team leads for 
the West Midlands was made after the review, and now 
answered.
4. Realigning with the national implementation pro-
gramme: the WMAHSN project fell back in line with 
the recording and reporting structure for the national 
PReCePT programme.
Structure of the distributed leadership model used
This comprised four clinicians (a) a consultant neonatol-
ogist from an NICU and an LNU, (b) a consultant obste-
trician with an interest in preterm birth prevention and 
(c) an obstetric senior trainee with an interest in quality 
improvement and preterm birth prevention (figure 1). 
They were supported by a WMAHSN project manager 
and project lead.
Roles within the regional lead clinical team
The trainee was nominated as the lead figure for the clin-
ical lead team to represent the region at national meet-
ings. The distributed leadership approach encouraged 
a team model based on reciprocal influence and reflec-
tion.5–11 This ensured that the trainee was mentored by 
three senior clinicians with diverse clinical experience to 
guide this project, allowing the trainee to flourish. At the 
same time, the trainee and team influenced their senior 
colleagues and they, one- another. The senior consultants 
acted as joint activators13 to and with the trainee who 
together synchronised their actions as to ensure delivery 
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of the regional clinical lead duties across the region. Each 
clinician took on responsibility for close communication 
with 3–4 obstetric and neonatal services in order to facil-
itate better relationship building through familiarity with 
individuals and teams within their own organisational 
context.
Impact of the regional lead clinical team
Overall uptake rates
There was a substantial and sustained increase in the 
regional administration rate of MgSO4 from the 2017 
benchmark of 58.6%2 to 85.5% for the period April 2019 
to March 2020 when the project was delivered. During 
that period, the administration rates each quarter were: 
Q1 81.8%, Q2 80.9%, Q3 87.1% and Q4 85.5%. Quarter 
4 administration rates dropped slightly due to the impact 
of COVID-19 on staffing and birthing behaviour during 
March 2020, this continued in to Q1 2020–2021. These 
reflect figures consistently close to or above the suggested 
national target set by the national programme, and 
also the developmental standard noted by the national 
neonatal audit programme, of 85%.3 The full data from 
this work are likely to be reported for the PReCePT 
programme, elsewhere.2
Regional collaborative guideline
The team cohesively worked towards the development 
and implementation of the first West Midlands regional 
combined obstetric and neonatal (ie, perinatal) guide-
lines. ‘West Midlands Guideline for the Administration of 
Magnesium Sulphate to Women in Preterm Labour for 
Fetal Neuroprotection’ published 6 July  2020. sixth
Audit of missed cases with regional impact
Through regional audit, the team were able to scrutinise 
reasons for poor uptake of MgSO4. Trust- specific learning 
points, missed opportunities for administration of MgSO4 
and identification of a practical regional time frame for 
administration of MgSO4 were possible through audit. 
These have informed the regional guideline.
Did the delivery of the programme meet the needs of the local 
PReCePT teams
In table 1, responses from stakeholders within individual 
trusts highlighted that the leadership approach was 
Figure 1 Distributed leadership model for WMAHSN delivery of a quality improvement project. FAQs, frequently asked 
questions; LNU, local neonatal unit; NICU, neonatal intensive care unit; WMAHSN, West Midlands Academic Health Science 
Network.
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experienced as participatory by trust- based stakeholders, 
based on mutual support and local ownership with the 
regional team responding to their needs and not the 
other way around.
DISCUSSION
The result of the critique of challenges posed in the West 
Midlands was the implementation of a clinical team of 
four, of diverse experience, functioning within the context 
of a collaborative of shared working. This resulted in the 
regional rates of uptake for MgSO4 in established preterm 
labour, reaching and exceeding the national set standard 
in a short space of time. It is difficult to tease out whether 
the uptake would have been equally successful had a 
purely hierarchical model been used if the first call had 
been answered, as opposed to the distributed leadership 
model we chose in the second call. Prior to implementing 
the distributed leadership model, the background rates 
of MgSO4 uptake were low, and care delivered around 
this time in the context of operational delivery networks, 
hierarchical in nature in the region. Therefore, we share 
the success of this project, as likely due to the distributed 
leadership model approach, but acknowledging that we 
have not explored contemporaneously, whether a hierar-
chical system approach may have delivered similar results 
for the region.
The development of the model emerged out of 
reflection as to why the original call was not heeded. 
Assuming individual responsibility in such a widely 
variant geographical area may have been considered 
too challenging by individual healthcare workers, espe-
cially, as the brief was to improve our existing rates of 
MgSO4 uptake from 58.6% to over 85%. The decision 
making around the team that coalesced thereafter took 
into account this potential reason for the poor initial 
response. In so doing a distributed leadership model 
evolved. In this model, all four team members worked 
alongside each other as part of the collective, enabling 
distribution of the workload between the team. This 
allowed the four members of the team to engage 
with different teams on the ground concurrently, in a 
more focused manner. Each of the team engaged with 
their units, and this was fairly independent of who was 
assigned as the spokesperson for the team. The team 
itself was not hierarchical. The junior trainee was 
supported and mentored through this process, and 
awarded the opportunity of representing work under-
taken in the region, on a national level. The group 
felt that this was important in the trainee’s growth and 
development. In planning and adopting this participa-
tory model based on reflection, mentoring and activa-
tion, the group worked together cohesively to display 
the characteristics of distributed leadership described.7
While the uptake for MgSO4 in the region may repre-
sent the effect of the ‘last wave’ of implementation,14 we 
believe its success was also due to a distributed leadership 
Table 1 The distributed leadership model in PReCePT: meeting the needs of the trust PReCePT teams
Questions Stakeholder group
Success criteria in relation to 
meeting needs and context Summary of responses
Can you describe how 
your team developed its 
implementation plan?
PReCePT teams n=10 Evidence of self- determined plans 
and absence of transactional 
relations
All responses describe implementation plans 
created by the trust PReCePT teams with an 
absence of regional teams’ transactional input. 
However, all teams used support resources 
provided by leadership team.
Do you feel that PReCePT 
has been owned by your team 
or has it been a top down 




Evidence of local ownership, 
ideally with a feeling of support 
from the regional team. Absence 
of transactional relations
HoMs and obstetric MD feel ownership had 
been local. PReCePT teams either say local 
ownership or a mixed approach with support 
being given by regional team.
Have you been involved as an 
equal partner in the regional 
project?
PReCePT teams n=10 Evidence of being an equal 
partner. Absence of transactional 
relations
Nine said yes and one unsure.
Has the regional project team 
responded to your needs in a 
timely way?
PReCePT teams n=10 Evidence of timely response 
without barriers
All responses said yes, with some adding 
additional positive comments.
How would you describe the 
regional project management 
approach? Has it been the right 
approach for your team?
PReCePT teams n=10 Evidence of positive comments, 
support and absence of 
transactional relations
All responses provided positive comments to 
approach taken, highlighting that support was 
there and that it worked for teams.
Were the regional management 
capabilities and capacities 
adequate?
PReCePT teams n=10 Evidence of positive responses Nine said yes one don’t know.
How effective was 
communication between the 
project team and the local 
trusts?
PReCePT teams n=10 Evidence of positive responses Eight positive, one not great, one reasonable.
HoMs, Heads of Midwifery; PReCePT, Preventing Cerebral Palsy in Preterm babies.
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model. Through scrutiny of all levels of questions posed 
by teams on the ground (adopters)4 because there were 
four heads instead of one, and audit of missed opportu-
nities with delineation of a regional practical time scale 
for administration of MgSO4, the responses focused on 
the needs of the adopters as they themselves highlighted 
during evaluation. In our opinion, this distributed lead-
ership approach contributed to improved uptake of 
the programme in hospitals that were struggling. The 
model potentially removed barriers found in a hierar-
chical system by giving ownership to the programme 
to teams on the ground. By using four individuals, we 
overcame the vast geographical and expertise diversity, 
as there was more opportunity for small group support, 
especially for smaller units that did not see as many 
cases as their bigger counterparts.
The value of this model translated into leads being 
present but not overbearing, enabling trust- based 
adopters to modify PReCePT based on site context- 
specific challenges. A commitment to participation, 
shared leadership responsibilities and reciprocal influ-
ence ensured that top- down transactional performance 
was not a feature of the project. The clinical leads 
were able to feed off the experiences of each other in 
accepting that individual units had their distinct style, 
and that the pace of change was not going to be consis-
tent for all units. This measured stance enabled a better 
understanding of the participatory philosophy12 this 
project so clearly displayed. Future implementation 
strategies for the NHS, especially in the context of cross- 
discipline work, such as between obstetrics and neonatal 
services are likely to benefit from more consistent utility 
of this and other distributed leadership models.
A limitation of this descriptive work is that the methods 
applied to the capture and analysis of qualitative data 
reflecting the adopter perspectives was developed to 
meet project management needs, at a time when the 
implementation phase was ongoing nationally. It is a 
consideration for future implementation work by the 
WMAHSN to plan for more in- depth external evalua-
tion of leadership methods applied.
The spread of an innovation does not in itself guar-
antee an improvement in outcomes if project focus is 
placed on monitoring the pace and scale of the adop-
tion. Indeed, the very act of ‘spreading an innovation’ 
is a risk to adoption that requires recognition and miti-
gation through a focus on the adopters not the innova-
tion. Here we describe a distributed leadership model 
that may be the way forward for NHS future perinatal 
quality improvement projects, given the complex cross- 
discipline interactions. Our experience suggests that at 
least for the West Midlands, this can be successful.
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